Access 2.8M+ Filings Sign Up Free
Oxurion NV Logo

Oxurion NV | OXUR - Profile, Filings, Stock Info & Investor Relations Data

Oxurion NV | OXUR
Filings & Investor Relations Data
Login to Watchlist

Create a free account or log in.

Industry
Biotechnology
Country
Belgium
Founded
1991
Oxurion NV (OXUR)

Company Profile

Website
Investor Relations

About Oxurion NV

Oxurion is on a mission to transform the treatment of retinal disorders, including the development of THR-149, its novel therapeutic for the treatment of DME.

Oxurion is a biopharmaceutical company developing next generation standard of care ophthalmic therapies, which are designed to improve and better preserve vision in patients with retinal vascular disorders including diabetic macular edema (DME), the leading cause of vision loss in working-age people worldwide.

Oxurion is headquartered in Leuven, Belgium, with corporate operations in Boston, MA, and is listed on Euronext Brussels under the symbol OXUR.

Market Presence

Worldwide

Headquarters

Gaston Geenslaan 1
3001, Heverlee
Belgium

Company Video

Video thumbnail
Click to load video from YouTube

Oxurion NV (OXUR)
Key Financial Data

AI-Powered Financial Insights Coming Soon

We are currently processing the filings for this company to provide automated financial statement analysis, key ratios, and risk summaries. Please check back later!

Unlock Full Company Insights & AI Chat

Create a free account or log in to add companies to your watchlist, access more data, and chat directly with filings using our AI assistant (as shown!).

Create Free Account Sign In

Oxurion NV (OXUR)
Filings & Annual Reports
Chat with AI, summarize, and extract data from processed filings! Look for the 'View & AI' button.

Quick Filters:

Advanced Filters

View all types
Filing Information Actions

Insider Trading Activity

↑
Bareldam SA (Close relation)
Buy EUR 1,700,000.00 EUR 1.44 07.03.22
◆
Lavinia D. Clay 2009 Revocable Trust (Close relation)
Other EUR 5,601,002.52 EUR 2.03 30.09.21

Oxurion NV (OXUR)
Stock & Investor Information

ISINs

BE0974487192

LEI

549300VWY8KVDFKLDM59

Stock Exchange Listings

Euronext Brussels

Primary Stock Exchange Listing

View Oxurion NV on main exchange

Industry Classification

Sector
Health Care
Industry
Biotechnology